Biose­cure law­mak­ers tell trade groups that Chi­na stud­ies are a new fo­cus

A con­gres­sion­al com­mit­tee fo­cused on US-Chi­na re­la­tions is ex­am­in­ing clin­i­cal tri­als run by multi­na­tion­al drug­mak­ers at sites af­fil­i­at­ed with the Chi­nese mil­i­tary and has be­gun …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.